CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Inotek Pharmaceuticals Corporation  (ITEK)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Inotek Pharmaceuticals's Quick Ratio

ITEK's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth



Select the Comparisons : Select the Ratio:                        

ITEK Quick Ratio (Sep 30 2017)
III. Quarter
(Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
Y / Y Current Liabilities Change -36.63 % -1.35 % 14.17 % 74.16 % 83.29 %
Y / Y Cash & cash equivalent Change -25.05 % 10.72 % 12.16 % 13.65 % 16.24 %
Quick Ratio MRQ 27.38 27.08 21.77 17.54 23.15
Overall Ranking # 94 # 96 # 128 # 128 # 0
Seq. Current Liabilities Change -6.2 % -23.77 % -26.96 % 21.33 % 46.01 %
Seq. Cash & cash equivalent Change -5.18 % -5.19 % -9.3 % -8.08 % 40.07 %



Quick Ratio third quarter 2017 Comment
Current Liabilities decreased faster than Inotek Pharmaceuticals's Cash & cash equivalent, this led to improvement in Inotek Pharmaceuticals's Quick Ratio to 27.38, Quick Ratio remained below Inotek Pharmaceuticals Corporation average.

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Quick Ratio than Inotek Pharmaceuticals in third quarter 2017. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are ITEK Segments?
See Quick Ratio ITEK on the trailing twelve month basis
Quick Ratio third quarter 2017 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 10
Overall Market # 94


Quick Ratio Statistics
High Average Low
36.5 24.38 17.54
(Sep 30 2015)   (Dec 31 2016)


You need to upgrade your Flash Player


Financial Statements
Inotek Pharmaceuticals's Current Liabilities $ 4 Millions Visit ITEK's Balance sheet
Inotek Pharmaceuticals's Cash & cash equivalent $ 103 Millions Visit ITEK's Balance sheet
Source of ITEK's Sales Visit ITEK's Sales by Geography




Companies with similar Quick Ratio in the quarter endingSep 30 2017, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2017 MRQ Cash & cash equivalentSep 30 2017 MRQ Current Liabilities
Syros Pharmaceuticals, Inc.  42.45 $ 82.141  Millions$ 1.935  Millions
Flex Pharma, Inc.  36.20 $ 38.929  Millions$ 1.075  Millions
Corvus Pharmaceuticals, Inc.  27.88 $ 99.700  Millions$ 3.576  Millions
Concert Pharmaceuticals, Inc.  27.81 $ 207.112  Millions$ 7.448  Millions
Intra-cellular Therapies, Inc.  27.63 $ 328.122  Millions$ 11.875  Millions
Inotek Pharmaceuticals Corporation  27.38 $ 103.125  Millions$ 3.767  Millions
Biospecifics Technologies Corp  27.33 $ 54.589  Millions$ 1.997  Millions
Geron Corp  24.15 $ 97.163  Millions$ 4.024  Millions
Kindred Biosciences, Inc.  23.74 $ 86.304  Millions$ 3.635  Millions
Endocyte Inc  23.71 $ 103.080  Millions$ 4.347  Millions
Achillion Pharmaceuticals Inc  22.29 $ 321.730  Millions$ 14.436  Millions
Abeona Therapeutics Inc.  21.42 $ 56.522  Millions$ 2.639  Millions
Loxo Oncology, Inc.  21.27 $ 371.669  Millions$ 17.470  Millions
Ovid Therapeutics Inc.  20.94 $ 96.480  Millions$ 4.608  Millions
Aldeyra Therapeutics, Inc.  19.80 $ 47.911  Millions$ 2.419  Millions
Dynavax Technologies Corp  19.54 $ 191.680  Millions$ 9.810  Millions
Contrafect Corp  17.94 $ 52.552  Millions$ 2.930  Millions
Marinus Pharmaceuticals Inc  17.68 $ 42.965  Millions$ 2.430  Millions
Glycomimetics Inc  17.29 $ 112.925  Millions$ 6.531  Millions
Sierra Oncology, Inc.  17.14 $ 107.824  Millions$ 6.290  Millions
Aquinox Pharmaceuticals, Inc  17.11 $ 119.695  Millions$ 6.997  Millions
Chimerix Inc  16.66 $ 149.720  Millions$ 8.987  Millions
Dermira, Inc.  16.27 $ 662.883  Millions$ 40.744  Millions
Tonix Pharmaceuticals Holding Corp.  15.97 $ 29.328  Millions$ 1.837  Millions
Minerva Neurosciences, Inc.  15.25 $ 133.010  Millions$ 8.720  Millions
China Yct International Group, Inc.  15.13 $ 20.698  Millions$ 1.368  Millions
Insmed Inc  14.97 $ 430.678  Millions$ 28.766  Millions
Paratek Pharmaceuticals, Inc.  14.61 $ 163.602  Millions$ 11.198  Millions
Xenon Pharmaceuticals Inc.  14.31 $ 43.772  Millions$ 3.058  Millions
Medicinova Inc  14.12 $ 24.535  Millions$ 1.738  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AMSU's Profile

Stock Price

AMSU's Financials

AMSU's Expectations

Business Description

Fundamentals

Charts & Quotes

AMSU's News

Suppliers

AMSU's Competitors

Customers & Markets

Economic Indicators

AMSU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com